NCT05459194View on ClinicalTrials.gov

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Asthma
Interventions
DEVICE

RP - TA

randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol combination administered with Elpenhaler®db (Rolenium®) versus the innovative one (Seretide Diskus®)

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY